Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00178984 · ClinicalTrials.gov registry record
Biomagnetic Characterization of Gastric Dysrhythmias:Study 2
A clinical trial of Ischemia, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 78
- Enrollment target
- 1
- Study location
NCT00178984: Completed study of Ischemia, sponsored by Vanderbilt University Medical Center.
NCT00178984 is a study of Ischemia that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 78 participants, below the 481-participant average among 11 other Ischemia trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00178984, a study of Ischemia, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 78 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to use the Squid magnetometer (Superconducting QUantum Interference Device) to help diagnose electrical and mechanical abnormalities of the stomach and intestines.
Conditions Studied
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2000-06 |
| Est. Completion | 2012-08-10 |
What the finished NCT00178984 record still lists
NCT00178984 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 78 participants, a relatively small participant target, below the 481-participant average among 11 other Ischemia trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Ischemia appearing as the primary indexed condition, and to 0 interventions.
NCT00178984 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT00178984 about?
NCT00178984 is a clinical study titled "Biomagnetic Characterization of Gastric Dysrhythmias:Study 2". The purpose of this study is to use the Squid magnetometer (Superconducting QUantum Interference Device) to help diagnose electrical and mechanical abnormalities of the stomach and intestines.
What is the current status of trial NCT00178984?
This trial is currently completed. The enrollment target is 78 participants. The study started on 2000-06. Estimated completion is 2012-08-10.
What conditions does trial NCT00178984 study?
This clinical trial studies the following conditions: Ischemia.
Who is sponsoring clinical trial NCT00178984?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00178984 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ischemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00178984's enrollment target sits among peer trials
78 12th of 11 the lowest of 11 other Ischemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ischemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
mHealth-CArdiac REhabilitation for INOCA
RECRUITING · NA
-
Circulating Markers for Ischemic Heart Disease
RECRUITING
-
Study of Circulating Monocytes in Patients With Ischemic Vascular Disease
RECRUITING
-
Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II
RECRUITING · NA
-
Evaluation of Patients With Non-obstructive Coronary Arteries
RECRUITING
-
The Chocolate Touch Study
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02397668 · 78 participants · NA
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- NCT03321656 · 78 participants · Phase 2
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- NCT03687814 · 78 participants · NA
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
- NCT04018872 · 78 participants · Phase 2
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia